VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION
LA PRESENTE INVENTION CONCERNE UN VECTEUR VIRAL D'EXPRESSION DE L'ALPHA-AT OU D'UN VARIANT DE L'ALPHA-AT CHOISI PARMI : AA ALPHA-AT, AA ALPHA-AT AA, AA ALPHA-AT ET LES VARIANTS CORRESPONDANTS DE LA FORME TRONQUEE DELTA 1 5 ALPHA-AT AINSI QUE DELTA 1 5 ALPHA-AT, CARACTERISE EN CE...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY |
| description | LA PRESENTE INVENTION CONCERNE UN VECTEUR VIRAL D'EXPRESSION DE L'ALPHA-AT OU D'UN VARIANT DE L'ALPHA-AT CHOISI PARMI : AA ALPHA-AT, AA ALPHA-AT AA, AA ALPHA-AT ET LES VARIANTS CORRESPONDANTS DE LA FORME TRONQUEE DELTA 1 5 ALPHA-AT AINSI QUE DELTA 1 5 ALPHA-AT, CARACTERISE EN CE QU'IL EST CONSTITUE D'UN VIRUS HYBRIDE DE LA VACCINE QUI COMPORTE UNE SEQUENCE D'ADN CODANT POUR LEDIT VARIANT DE L'ALPHA-AT INSERE DANS UNE PARTIE NON ESSENTIELLE DU GENOME DU VIRUS ET SOUS LE CONTROLE D'UNE SEQUENCE D'EXPRESSION EFFICACE DANS LA VACCINE.
A viral expression vector of alpha1-AT or of a variant of alpha1-AT, chosen from: [AA ]alpha1-AT, [AA ]alpha1-AT[AA ,AA ]alpha1-AT and the corresponding variants of the truncated form [delta 1->5]alpha1-AT and [delta 1->5]alpha1-AT, characterised in that it consists of a hybrid virus of the vaccine which contains a DNA sequence coding for the said variant of alpha1-AT inserted into a nonessential part of the virus genome and under the control of an expression sequence which is effective in the vaccine. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FR2601033A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FR2601033A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FR2601033A13</originalsourceid><addsrcrecordid>eNqNi7EKwjAUALM4iPoPb3MqtAbcH_HVBGISXlIhUykSJ9FC_X-M4Ac4HQd3a8FXZIMuRTgR2D3aoLGpbhLnGIwj0MMFvzzbrHzMlggoQWCvqC7BDwwWq1NAxmS824rVfXosZffjRkBPSemmzK-xLPN0K8_yHns-HNuulRI7-UfyAYExL0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION</title><source>esp@cenet</source><creator>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</creator><creatorcontrib>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</creatorcontrib><description>LA PRESENTE INVENTION CONCERNE UN VECTEUR VIRAL D'EXPRESSION DE L'ALPHA-AT OU D'UN VARIANT DE L'ALPHA-AT CHOISI PARMI : AA ALPHA-AT, AA ALPHA-AT AA, AA ALPHA-AT ET LES VARIANTS CORRESPONDANTS DE LA FORME TRONQUEE DELTA 1 5 ALPHA-AT AINSI QUE DELTA 1 5 ALPHA-AT, CARACTERISE EN CE QU'IL EST CONSTITUE D'UN VIRUS HYBRIDE DE LA VACCINE QUI COMPORTE UNE SEQUENCE D'ADN CODANT POUR LEDIT VARIANT DE L'ALPHA-AT INSERE DANS UNE PARTIE NON ESSENTIELLE DU GENOME DU VIRUS ET SOUS LE CONTROLE D'UNE SEQUENCE D'EXPRESSION EFFICACE DANS LA VACCINE.
A viral expression vector of alpha1-AT or of a variant of alpha1-AT, chosen from: [AA ]alpha1-AT, [AA ]alpha1-AT[AA ,AA ]alpha1-AT and the corresponding variants of the truncated form [delta 1->5]alpha1-AT and [delta 1->5]alpha1-AT, characterised in that it consists of a hybrid virus of the vaccine which contains a DNA sequence coding for the said variant of alpha1-AT inserted into a nonessential part of the virus genome and under the control of an expression sequence which is effective in the vaccine.</description><edition>4</edition><language>fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1988</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19880108&DB=EPODOC&CC=FR&NR=2601033A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19880108&DB=EPODOC&CC=FR&NR=2601033A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</creatorcontrib><title>VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION</title><description>LA PRESENTE INVENTION CONCERNE UN VECTEUR VIRAL D'EXPRESSION DE L'ALPHA-AT OU D'UN VARIANT DE L'ALPHA-AT CHOISI PARMI : AA ALPHA-AT, AA ALPHA-AT AA, AA ALPHA-AT ET LES VARIANTS CORRESPONDANTS DE LA FORME TRONQUEE DELTA 1 5 ALPHA-AT AINSI QUE DELTA 1 5 ALPHA-AT, CARACTERISE EN CE QU'IL EST CONSTITUE D'UN VIRUS HYBRIDE DE LA VACCINE QUI COMPORTE UNE SEQUENCE D'ADN CODANT POUR LEDIT VARIANT DE L'ALPHA-AT INSERE DANS UNE PARTIE NON ESSENTIELLE DU GENOME DU VIRUS ET SOUS LE CONTROLE D'UNE SEQUENCE D'EXPRESSION EFFICACE DANS LA VACCINE.
A viral expression vector of alpha1-AT or of a variant of alpha1-AT, chosen from: [AA ]alpha1-AT, [AA ]alpha1-AT[AA ,AA ]alpha1-AT and the corresponding variants of the truncated form [delta 1->5]alpha1-AT and [delta 1->5]alpha1-AT, characterised in that it consists of a hybrid virus of the vaccine which contains a DNA sequence coding for the said variant of alpha1-AT inserted into a nonessential part of the virus genome and under the control of an expression sequence which is effective in the vaccine.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1988</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7EKwjAUALM4iPoPb3MqtAbcH_HVBGISXlIhUykSJ9FC_X-M4Ac4HQd3a8FXZIMuRTgR2D3aoLGpbhLnGIwj0MMFvzzbrHzMlggoQWCvqC7BDwwWq1NAxmS824rVfXosZffjRkBPSemmzK-xLPN0K8_yHns-HNuulRI7-UfyAYExL0A</recordid><startdate>19880108</startdate><enddate>19880108</enddate><creator>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</creator><scope>EVB</scope></search><sort><creationdate>19880108</creationdate><title>VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION</title><author>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FR2601033A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>1988</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION</title><date>1988-01-08</date><risdate>1988</risdate><abstract>LA PRESENTE INVENTION CONCERNE UN VECTEUR VIRAL D'EXPRESSION DE L'ALPHA-AT OU D'UN VARIANT DE L'ALPHA-AT CHOISI PARMI : AA ALPHA-AT, AA ALPHA-AT AA, AA ALPHA-AT ET LES VARIANTS CORRESPONDANTS DE LA FORME TRONQUEE DELTA 1 5 ALPHA-AT AINSI QUE DELTA 1 5 ALPHA-AT, CARACTERISE EN CE QU'IL EST CONSTITUE D'UN VIRUS HYBRIDE DE LA VACCINE QUI COMPORTE UNE SEQUENCE D'ADN CODANT POUR LEDIT VARIANT DE L'ALPHA-AT INSERE DANS UNE PARTIE NON ESSENTIELLE DU GENOME DU VIRUS ET SOUS LE CONTROLE D'UNE SEQUENCE D'EXPRESSION EFFICACE DANS LA VACCINE.
A viral expression vector of alpha1-AT or of a variant of alpha1-AT, chosen from: [AA ]alpha1-AT, [AA ]alpha1-AT[AA ,AA ]alpha1-AT and the corresponding variants of the truncated form [delta 1->5]alpha1-AT and [delta 1->5]alpha1-AT, characterised in that it consists of a hybrid virus of the vaccine which contains a DNA sequence coding for the said variant of alpha1-AT inserted into a nonessential part of the virus genome and under the control of an expression sequence which is effective in the vaccine.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | fre |
| recordid | cdi_epo_espacenet_FR2601033A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TIM%20SKFRN,%20SOPHIE%20JALLAT%20ET%20MICHAEL%20COURTNEY&rft.date=1988-01-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFR2601033A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |